Evidence map›Paper›PMID 34937665›Full record

Observational studyFertility and sterility2022

Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test.

Gilbert G G Donders, Eugene Bosmans, Jente Reumers, Francesca Donders, Jef Jonckheere, Geert Salembier, Nora Stern, Yves Jacquemyn, Willem Ombelet, Christophe E Depuydt

Abstract readObservational StudyValidation Study
In one paragraph

Observational study in Fertility and sterility, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gilbert G G DondersUniversity Hospital Antwerpen, Antwerp, Belgium; Femicare, Clinical Research for Women, Tienen, Belgium; Department of Obstetrics and Gynecology, Regional Hospital Heilig Hart, Tienen, Belgium. Electronic address: gilbert.donders@uza.be.
Eugene BosmansDepartment of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical and Molecular Pathology, AML, Sonic Healthcare, Antwerp, Belgium.
Jente ReumersFemicare, Clinical Research for Women, Tienen, Belgium.
Francesca DondersFemicare, Clinical Research for Women, Tienen, Belgium.
Jef JonckheereDepartment of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical Microbiology, AML, Sonic Healthcare, Antwerp, Belgium.
Geert SalembierDepartment of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical Microbiology, AML, Sonic Healthcare, Antwerp, Belgium.
Nora SternHôpital Universitaire Des Enfants Reine Fabiola, Brussels, Belgium.
Yves JacquemynUniversity Hospital Antwerpen, Antwerp, Belgium.
Willem OmbeletGenk Institute for Fertility Technology, Ziekenhuis Oost-Limburg (ZOL) Hospitals, Genk, Belgium.
Christophe E DepuydtDepartment of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical and Molecular Pathology, AML, Sonic Healthcare, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the contagiousness of sperm and its influence on fertility after recovery from COVID-19 infection.

designProspective cohort study.

settingUniversity medical center. PATIENT(S): One hundred twenty Belgian men who had recovered from proven COVID-19 infection. INTERVENTION(S): No intervention was performed. MAIN OUTCOME MEASURE(S): Semen quality was assessed using the World Health Organisation criteria. DNA damage to sperm cells was assessed by quantifying the DNA fragmentation index and the high density stainability. Finally antibodies against SARS-CoV2 spike-1 antigen, nuclear and S1-receptor binding domain were measured by Elisa and chemilumenscent microparticle immunoassays, respectively. RESULT(S): SARS-CoV-2 RNA was not detected in semen during the period shortly after infection nor at a later time. Mean progressive motility was reduced in 60% of men tested shortly (<1 month) after COVID-19 infection, 37% of men tested 1 to 2 months after COVID-19 infection, and 28% of men tested >2 months after COVID-19 infection. Mean sperm count was reduced in 37% of men tested shortly (<1 month) after COVID-19 infection, 29% of men tested 1 to 2 months after COVID-19 infection, and 6% of men tested >2 months after COVID-19 infection. The severity of COVID-19 infection and the presence of fever were not correlated with sperm characteristics, but there were strong correlations between sperm abnormalities and the titers of SARS-CoV-2 IgG antibody against spike 1 and the receptor- binding domain of spike 1, but not against nucleotide, in serum. High levels of antisperm antibodies developed in three men (2.5%). CONCLUSION(S): Semen is not infectious with SARS-CoV-2 at 1 week or more after COVID-19 infection (mean, 53 days). However, couples with a desire for pregnancy should be warned that sperm quality after COVID-19 infection can be suboptimal. The estimated recovery time is 3 months, but further follow-up studies are under way to confirm this and to determine if permanent damage occurred in a minority of men.

Indexed as

AdultAntibodies, ViralCOVID-19COVID-19 Nucleic Acid TestingDNA DamageDNA FragmentationHumansImmunoglobulin GInfertility, MaleMaleProspective StudiesRNA, ViralSARS-CoV-2SemenSemen AnalysisSpermatozoaAntibodies, ViralImmunoglobulin GRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2DNA fragmentation indexinfertilityreal-time quantitative PCRtest validationtransmission risk

Identifiers

PMID34937665
PMCPMC8685303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.